SEC Form 4 · accession 0001127602-18-029515
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dwight E Ellingwood
Director
Period of report
Oct 4, 2018
Accepted (ET)
Oct 4, 2018 · 10:55 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 4, 2018 | M | 1,000 | $12.80 | A | 8,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $12.80 | Oct 4, 2018 | M | 1,000 | D | — | Jan 25, 2027 | Common Stock | 1,000 | 11,000 | D |
Explanation of responses
- F1These options became fully vested in January 2018.